BGP Litigation Helps Defend the Renowned Pharmaceutical Holding PharmVILAR in a Patent Dispute
The Intellectual Property and Technology Practice at BGP Litigation successfully defended the interests of PharmVILAR, a leading contract manufacturer and renowned distributor of pharmaceutical products in Russia and the CIS, in a patent dispute before the Praesidium of the Intellectual Property Court (IPC).
In 2020, one of the holding’s companies PharmVILAR challenged a competitor's patent for a group of inventions in Rospatent. Yet, the IPC and, subsequently, its Praesidium overturned the decision and instructed Rospatent to reconsider the opposition. Upon reconsideration, Rospatent once again declared the patent invalid.
PharmVILAR successfully demonstrated that the claims of the group of inventions included features not disclosed in the original application materials. It was also shown that the substance “lappaconitine” mentioned in the claims was not identical to “lappaconitine hydrobromide” referenced in the application materials.